Stay updated with breaking news from License Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Dina Kartit (Reuters) -China's National Medical Products Administration (NMPA) has approved Zai Lab Limited's and Argenx SE's Biologics License ...
IDLA offers option to stay in safety of your car With so many news reports covering roadside encounters that lead to needless violence harm and often fatalities
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Markets for Advanced Wound Management Technologies" report has been added to ResearchAndMarkets.com's...
/PRNewswire/ -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and...
IO Biotech (NASDAQ: IOBT) randomized 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) in